Literature DB >> 1892752

Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors.

T T Kwok1, R M Sutherland.   

Abstract

Previous studies have shown that the presence of epidermal growth factor (EGF) after irradiation enhanced the radiosensitivity of CaSki cells. To examine the role of EGF receptor density and related growth response in EGF associated radiosensitisation, four human squamous carcinoma cell lines were used. The total number of EGF receptors for HN5, A431, CaSki, and SiHa cells is 5.2 x 10(6), 1.6 x 10(6), 7.9 x 10(5) and 1.1 x 10(5) respectively, and the dissociation constant (Kd) for low affinity EGF receptors is 11.8, 3.8, 1.7 and 0.8 nM respectively. The Kd for high affinity receptors differs slightly among the four cell lines, 0.09 to 0.21 nM. EGF inhibited the growth of A431, CaSki, and HN5 cells, but stimulated the growth of SiHa cells. Due to the presence of 10 ng ml-1 EGF after irradiation, radiosensitivity enhancement associated with reduced shoulder size of the survival curve was observed. The extent of sensitisation was similar for A431, CaSki, and HN5 cells, with no effect on SiHa cells. At this concentration, EGF present during the clonogenic assay period after irradiation also reduced the plating efficiency (PE) of the monolayer cultures of A431, CaSki, and HN5 cells, but increased that of SiHa cells. The radiation response of mouse 3T3 cells (less than 5,000 receptors) was not sensitised by EGF. A similar level of radiosensitivity enhancement by EGF was observed for parental and conditioned A431 cultures. The conditioned cells were grown in 50 ng ml-1 EGF for 10 weeks and did not demonstrate growth inhibition and PE reduction by treatment with EGF. The EGF receptor numbers and binding affinity of these cells were the same as for the parental cells. The results from the conditioned cells support the hypothesis that EGF related radiosensitisation is EGF receptor density dependent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1892752      PMCID: PMC1977524          DOI: 10.1038/bjc.1991.286

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

Review 1.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

Review 2.  Receptors for epidermal growth factor and other polypeptide mitogens.

Authors:  G Carpenter
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 3.  Transmembrane signalling at the epidermal growth factor receptor.

Authors:  A Pandiella; L Beguinot; L M Vicentini; J Meldolesi
Journal:  Trends Pharmacol Sci       Date:  1989-10       Impact factor: 14.819

Review 4.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

5.  Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology.

Authors:  F Friedl; I Kimura; T Osato; Y Ito
Journal:  Proc Soc Exp Biol Med       Date:  1970-11

6.  Analysis of morphology and receptor metabolism in clonal variant A431 cells with differing growth responses to epidermal growth factor.

Authors:  A Lifshitz; C S Lazar; J E Buss; G N Gill
Journal:  J Cell Physiol       Date:  1983-06       Impact factor: 6.384

7.  Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line.

Authors:  R A Pattillo; R O Hussa; M T Story; A C Ruckert; M R Shalaby; R F Mattingly
Journal:  Science       Date:  1977-06-24       Impact factor: 47.728

8.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

9.  Biological effect of epidermal growth factor on the in vitro growth of human tumors.

Authors:  S E Singletary; F L Baker; G Spitzer; S L Tucker; B Tomasovic; W A Brock; J A Ajani; A M Kelly
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

10.  Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.

Authors:  D M Easty; G C Easty; R L Carter; P Monaghan; L J Butler
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

View more
  16 in total

1.  Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

Authors:  Terrance G Johns; Rodney B Luwor; Carmel Murone; Francesca Walker; Janet Weinstock; Angela A Vitali; Rushika M Perera; Achim A Jungbluth; Elisabeth Stockert; Lloyd J Old; Edouard C Nice; Antony W Burgess; Andrew M Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

Review 2.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.

Authors:  Takashi Yamatodani; Lars Ekblad; Elisabeth Kjellén; Anders Johnsson; Hiroyuki Mineta; Johan Wennerberg
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-24       Impact factor: 4.553

Review 4.  Cell-signaling targets for antitumour drug development.

Authors:  V G Brunton; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 5.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

Review 6.  Nuclear translocation of the epidermal growth factor receptor family membrane tyrosine kinase receptors.

Authors:  Shao-Chun Wang; Mien-Chie Hung
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.

Authors:  Jeroen J Lammerts van Bueren; Wim K Bleeker; Annika Brännström; Anne von Euler; Magnus Jansson; Matthias Peipp; Tanja Schneider-Merck; Thomas Valerius; Jan G J van de Winkel; Paul W H I Parren
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

8.  Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture.

Authors:  K Aizawa; I Muto; S Suzuki; N Tanaka; H Yabusaki; S Tanaka; N Katayanagi; T Suzuki; O Tanaka; T Muto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 9.  Cellular responses to EGFR inhibitors and their relevance to cancer therapy.

Authors:  Pinaki R Dutta; Amit Maity
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

10.  Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7.

Authors:  Felicity C Kalinowski; Keith M Giles; Patrick A Candy; Alishum Ali; Clarissa Ganda; Michael R Epis; Rebecca J Webster; Peter J Leedman
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.